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Direct Stenting for Stable Angina
Pectoris Is Associated With Reduced
Periprocedural Microcirculatory Injury
Compared With Stenting After Pre-Dilation
Thomas Cuisset, MD, Michalis Hamilos, MD, Narbeh Melikian, MD, Eric Wyffels, MD,
Jaydeep Sarma, MD, Giovanna Sarno, MD, Emanuele Barbato, MD, Jozef Bartunek, MD,
William Wijns, MD, PHD, Bernard De Bruyne, MD, PHD
Aalst, Belgium
Objectives We conducted a randomized study to compare the effect of direct stenting (DS) and conventional stenting (CS)
on post-procedural index of microcirculatory resistance (IMR) values.
Background Direct stenting has been suggested to reduce periprocedural microcirculatory injury compared with stenting that
follows pre-dilation (CS). The index of microcirculatory resistance is a sensitive invasive marker of coronary mi-
crovascular resistance.
Methods Fifty patients admitted for elective percutaneous coronary intervention (PCI) were included. All patients had sta-
ble angina (Canadian Cardiovascular Society class IV) related to a lesion suitable for DS and were randomized
to DS (n  25) or CS (n  25). Baseline demographics and clinical and procedural data were comparable in
both groups. An intracoronary pressure/temperature sensor-tipped guide wire was used. Thermodilution curves
were obtained at baseline and during maximal hyperemia achieved by infusion of intravenous adenosine. The
index of microcirculatory resistance was calculated from the ratio of the mean distal coronary pressure at maxi-
mal hyperemia to the inverse of mean hyperemic transit time.
Results After otherwise-uneventful PCI, patients treated with CS had significantly greater IMR (DS 13  3, CS 24  14;
p  0.01) and tended to have greater post-PCI troponin T values (DS 0.035  0.04, CS 0.17  0.02; p  0.07).
In the whole sample, 20% of patients had post-PCI troponin release (troponin T 0.03 ng/ml). Patients with tro-
ponin elevation had significantly greater post-PCI IMR values than patients without troponin elevation: 24.7 
13.2 versus 16.9  10.2; p  0.04.
Conclusions In patients undergoing successful coronary stenting for stable angina, DS is associated with reduced microvascu-
lar dysfunction induced by PCI as compared with CS. (J Am Coll Cardiol 2008;51:1060–5) © 2008 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.11.059(
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itents are now deployed in as many as 95% of all percutaneous
oronary interventions (PCIs). Improvements in balloon and
tent technology have permitted the development of the “direct
tenting” (DS) strategy (stent delivery without pre-dilation)
nstead of conventional stenting (CS), that is, stent implanta-
ion after balloon pre-dilation. Several studies demonstrated
his technique to be feasible and safe in selected cases resulting
n reduced procedural costs, duration, and radiation exposure
1). However, in randomized trials, the DS technique showed
imilar results to standard CS for long-term clinical outcome
rom the Cardiovascular Center, OLV Hospital, Aalst, Belgium.r
Manuscript received September 18, 2007; revised manuscript received November 6,
007, accepted November 13, 2007.2–13). Experimental and indirect clinical data support the
oncept of reduced wall damage and distal embolization when
tent deployment is performed without balloon pre-dilation
14,15). These data suggest a benefit of DS over CS in terms
f reduced post-procedural microvascular impairment. The
ndex of microcirculatory resistance (IMR) is validated as a
ovel invasive index of microcirculatory resistance for assessing
he status of the microcirculation independently of the epicar-
ial area (16). The IMR is derived from distal coronary
ressure and hyperemic mean transit time (16–18). We con-
ucted a prospective and randomized study to evaluate the
enefit of DS, in comparison with CS, on microvascular
mpairment assessed by post-PCI IMR values and troponin
elease in elective PCI for stable angina.
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rial design and randomization. This was a randomized,
rospective, single-center study. Patients were randomized
ither to DS or CS procedure in a 1:1 ratio.
atient and lesion selection. Between March and July
007, 50 patients (age 18 years) with stable angina or a
ositive functional study with a planned PCI procedure of a
ingle de novo lesion 50% and 100% diameter stenosis
n a native coronary artery were randomized. The invasive
hysiological assessment of the lesion had to confirm the
emodynamic significance of the lesion severity with a
ractional flow reserve (FFR) 0.80. All included lesions
ere deemed suitable for both DS and CS according to 2
ndependent interventionalists. Exclusion criteria were left
entricular ejection fraction 30%, acute coronary syn-
rome in the previous month, previous myocardial infarc-
ion (MI) in the target vessel–related territory, positive
iomarkers before PCI, chronic total occlusion, intrastent
estenosis, bifurcation with side branch 2 mm, ostial
esion, lesions with extensive calcifications or containing
hrombus, and contraindications to adenosine. The study
rotocol was approved by the institutional ethics committee
f OLV Hospital, and patients gave informed consent for
articipation and data collection.
djunctive medications. Antiplatelet therapy was admin-
stered with a loading dose of 600 mg of clopidogrel and 500
g of aspirin the day before the procedure regardless of
ackground therapy. During catheterization, all patients
eceived intravenous heparin bolus sufficient to attain an
ctivated clotting time of 250 to 300 s. Use of glycoprotein
Ib/IIIa antagonists was left to the physician’s discretion.
ardiac catheterization protocol. Coronary physiological
ndexes (coronary flow reserve [CFR], IMR, and FFR)
ere measured in each patient before (FFR only) and
fter PCI (all indexes) using previously described princi-
les and methods (16 –18). An intracoronary pressure/
emperature sensor-tipped guide wire (Radi pressure wire,
ertus-Radi Medical Systems, Uppsala, Sweden) was used
o measure distal coronary pressure and to derive thermodi-
ution curves. Thermodilution curves were obtained (in
riplicate) from a hand-held, 3-ml brisk (0.25 s) injection
f room temperature saline at baseline and at maximal
yperemia (Fig. 1). Maximal hyperemia was achieved by
nfusion of 140 g/kg/min of adenosine via the femoral
ein. Mean transit time (Tmn) at baseline and maximal
yperemia were derived from thermodilution curves.
imultaneous recordings of mean aortic pressure (from
he guiding catheter) and mean distal coronary pressure
from the distal pressure sensor) were also made at
aseline and maximal hyperemia. We calculated CFR
rom the ratio of hyperemic to baseline Tmn. We calcu-
ated IMR from the ratio of the mean distal coronary
ressure at maximal hyperemia to the inverse of mean
yperemic Tmn. We calculated FFR from the ratio of distal to
roximal pressures at maximal hyperemia (Fig. 1). statistical analysis. Statistical
nalysis was performed with the
raphpad Prism Software (v.
.00, Graphpad Software Inc.,
an Diego, California). An esti-
ate of mean post-PCI values of
MR was obtained from the pub-
ished literature (16 –18). We
alculated that at least 20 pa-
ients should be included in each
roup to detect a difference of
0% between the DS and the CS
roup (alpha 0.05, beta 0.20, and
tatistical power 0.80). There-
ore, we targeted a sample of 25
atients per group. Continuous
ariables were presented as mean  SD. Unpaired t test or
ann-Whitney U test were used to analyse differences in
ontinuous variables. The Fisher exact or chi-square test was
sed to analyze differences between categorical variables.
earson correlation coefficients (2-sided) were derived to
ssess the relationship between IMR, CFR, and FFR and
ontinuous baseline variables. A stepwise multiple regres-
ion model was produced to identify independent determi-
ants of IMR. Data were evaluated using an intent-to-treat
nalysis. Statistical significance was set at p values 0.05.
esults
atient characteristics. Among the 25 patients random-
zed to DS, 24 eventually underwent successful DS. Baseline
emographics and clinical and biological data were similar
n both groups (Table 1). Angiographic data, pre-PCI FFR,
inimum lumen diameter, and percentage of stenosis were
omparable in both groups (Table 2).
hysiological measurements. After PCI, physiological
arameters were successfully obtained in all patients. Frac-
ional flow reserve values were similar in both groups, and
MR values were significantly lower in patients undergo-
ng DS than CS: 13  3 and 24  14, respectively, p 
.01 (Table 2, Fig. 2). By using multivariate analysis
ntegrating baseline clinical, biological, and procedural
arameters, we found that the presence or absence of
re-dilation was the only independent determinant of
ost-PCI IMR (odds ratio 11.1, 95% confidence interval
.0 to 17.1, p  0.01).
In the whole sample, we observed a moderate negative
orrelation between IMR and CFR (r  0.38, p  0.006)
Fig. 3A), but there was no correlation between IMR and
FR (r  0.15; p  0.10) (Fig. 3B). Interestingly, the
ost-PCI CFR values were not significantly different be-
ween the DS and CS groups: 3.3  1.6 and 3  1.9,
espectively (p  0.64) (Table 2).
Figure 1 represents 2 cases of successful PCI without any
lectrocardiographic (ECG) changes, recurrent chest pain,
Abbreviations
and Acronyms
CFR  coronary flow
reserve
CS  conventional stenting
DS  direct stenting
FFR  fractional flow
reserve
IMR  index of
microcirculatory resistance
MI  myocardial infarction
PCI  percutaneous
coronary intervention
Tmn  mean transit timeide branch loss, or other periprocedural complications.
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Direct Stenting and Microcirculatory Injury March 18, 2008:1060–5atient A was treated for stable angina in a mid-right
oronary artery (RCA) with direct stenting (3 mm diameter,
5 mm length) at 12 atmospheres and after dilation with
hort noncompliant balloon (3 mm diameter, 9 mm length).
ost-PCI IMR was 9 (Fig. 1A), and there was no post-PCI
roponin elevation. Patient B was planned for elective PCI
f a distal RCA stenosis. He underwent conventional
tenting with pre-dilation (2.5 mm diameter, 12 mm
ength) followed by stent deployment (3 mm diameter, 13
m length). Post-PCI IMR was 54, and he exhibited
ost-PCI troponin elevation (troponin T  0.042). These
Figure 1 Measurement of Post-PCI IMR After PCI
IMR  Pd hyperhemia · Tmn hyperhemia. (A) Patient A undergoing direct stenting w
tional stenting with higher post-PCI IMR value and troponin release (troponin T  0
of microcirculatory resistance; Pa  arterial pressure; PCI  percutaneous coronaases illustrate the high sensitivity of IMR and troponin T ror detection of microvascular injury, even in the absence of
ny clinical symptoms or ECG changes.
eriprocedural MI and ECG changes. After PCI, 20% of
atients (n  10) had troponin T elevation 0.03 ng/ml (3
imes the 99th percentile of the normal population). Pa-
ients undergoing DS tended to have lower periprocedural
I than those with CS, with mean values of post-PCI
roponin T of 0.035  0.04 and 0.17  0.02, respectively
p  0.07). Mean post-PCI IMR values were significantly
reater in patients with periprocedural MI (n  10) than in
atients without (n  40): 24.7  13.3 and 16.9  10.2
post-PCI IMR value and no troponin release. (B) Patient B undergoing conven-
ng/ml). CFR  coronary flow reserve; FFR  fractional flow reserve; IMR  index
vention; Pd  distal pressure; Tmn  mean transit time.ith low
.042
ry interespectively (p  0.04).
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he results of the present study suggest a benefit of DS over
S in elective PCI based on lower levels of post-PCI
icrovascular resistance. In addition, patients with peripro-
Baseline Characteristics of the Patients
Table 1 Baseline Characteristics of the Pat
Characteristics
Direct S
(n 
Gender, male 18 (7
Age, yrs 67 
Body mass index, kg/m2 27 
Cardiovascular risk factors
Hypertension 18 (7
Diabetes mellitus 6 (2
Smoker 7 (2
Dyslipidemia 16 (6
Familial history 5 (2
Previous PCI/MI 8 (3
Medications
Statins 16 (6
Beta-blocker 11 (4
ACE inhibitor 7 (2
Diabetic therapy 5 (2
Nitrates 5 (2
GP IIb/IIIa antagonists 0 (0
Left ventricular ejection fraction, % 64 
Biological data
Creatinine, mg/dl 1.1 
C-reactive protein, mmol/l 2.6 
Values are mean  SD for quantitative variables and n (%) for qualita
ACE  angiotension-converting enzyme; GP  glycoprotein; MI  m
Procedural Characteristics and Results
Table 2 Procedural Characteristics and Res
Characteristics
Direct Stentin
(n  25)
Culprit vessel
LAD 13 (52)
RCA 6 (24)
Circumflex 6 (24)
Reference diameter 2.9 0.6
Minimal lumen diameter 1 0.4
Percent stenosis 60 8.3
No. of stents 1.2 0.4
Total stent length, mm 18.8 5.9
Stent diameter, mm 2.96 0.3
Post-dilation 4 (16)
Drug-eluting stent 15 (60)
Maximal pressure inflation 14.2 2
Physiological data
FFR pre-PCI 0.70 0.1
FFR post-PCI 0.91 0.1
IMR post-PCI 13 3.3
CFR post-PCI 3.3 1.6
Post-PCI troponin T, ng/ml 0.035 0.04
Values are mean  SD for quantitative variables and n (%) for qualita
CFR  coronary flow reserve; FFR  fractional flow reserve; IMR  index o
PCI  percutaneous coronary intervention; RCA  right coronary artery.edural troponin release had higher IMR values after PCI.
icrovascular embolization during PCI identified by post-
CI troponin T release has been shown to be associated
ith increased mortality (19). A recent study that used
ntracoronary Doppler wire measurements has shown that
Conventional Stenting
(n  25) p Value
19 (76) 0.92
65  12 0.54
28  4.5 0.32
16 (64) 0.54
5 (20) 0.73
9 (36) 0.67
15 (60) 0.77
6 (24) 0.73
11 (44) 0.38
17 (68) 0.76
15 (60) 0.26
6 (24) 0.74
4 (16) 0.71
3 (12) 0.44
0 (0) 1.0
63.3  12 0.85
1.0  0.3 0.35
2.2  2.3 0.64
iables.
ial infarction; PCI  percutaneous coronary intervention.
Conventional Stenting
(n  25) p Value
9 (36) 0.11
10 (40) 0.08
6 (24) 1
2.9 0.7 0.64
1.1 0.6 0.78
65 11 0.11
1.2 0.4 0.49
21.5 10 0.25
2.98 0.3 0.84
5 (20) 0.71
19 (76) 0.36
14.7 2 0.33
0.66 0.1 0.25
0.91 0.1 0.60
24.1 14 0.005
3 1.9 0.64
0.17 0.02 0.07
iables.ients
tenting
25)
2)
10
3.6
2)
4)
8)
4)
0)
2)
4)
4)
8)
0)
0)
)
9
0.3
2ults
g
tive var
f microcirculatory resistance; LAD  left anterior descending artery;
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Direct Stenting and Microcirculatory Injury March 18, 2008:1060–5eriprocedural troponin elevation is significantly associated
ith microembolism and that crossing the stenosis with
alloon or stent over the guidewire was a critical phase
ssociated with intracoronary microemboli (20). Accord-
ngly, we have hypothesized a potential benefit of DS over
S for reduction of periprocedural microembolization. Cor-
nary flow reserve has been evaluated to assess post-PCI
mbolization. However, Hori et al. (21,22) showed that
mpaired CFR post-PCI was also related to increased
aseline average peak velocity related to adenosine release
uring PCI. Likewise, in our study, CFR measurements
ere unable to identify a benefit of DS over CS with respect
o rates of PCI-related microvascular injury because the
rolonged hyperemia that follows the repeated ischemic
pisodes caused by PCI makes it difficult to obtain ther-
odilution curves in a basal state, which confounds post-
CI CFR values. Recently, IMR has been proposed as a
ew invasive marker to assess the microvascular coronary
ed (16–18). This marker was used to assess microcircula-
ion in different clinical settings, such as reperfusion in acute
I (23) and after heart transplantation (24). In the present
tudy, significantly greater IMR values were measured in
atients with post-PCI troponin release. We found that
MR was increased in a number of cases not showing
roponin release, indicating that microvascular injury after
CI can occur in the absence of detectable significant
yonecrosis. The debate between DS and CS has not yet
een resolved. The potential disadvantages and risks of DS
emain clear: higher risk of failure to cross with DS, which
an lead to stent loss, temporary acute coronary occlusion, or
Figure 2 Distribution of IMR Values Among Patients Undergoing
DS or CS According to Post-PCI Troponin Values
Closed circles  troponin positive; open circles  troponin negative. CS 
conventional stenting; DS  direct stenting; IMR  index of microcirculatory
resistance; PCI  percutaneous coronary intervention.rauma at the coronary ostium and inadequate choice oftent diameter or length. Direct stenting also has been
ssociated with potential advantages: reduced procedural
ost, use of contrast agent and X-ray time (2,13), and
eduction in total ischemic time. Direct stenting also could
e associated with reduced vessel wall injury that can cause
issections, thrombosis, and distal embolization, in partic-
lar at the stent edges (14). Indeed, in specific lesion subsets
uch as PCI of the saphenous venous graft, Webb et al. (25)
ave shown less distal embolization with DS versus CS.
ost of the available clinical studies have been conducted
ith bare-metal stents. With the introduction of drug-
luting stents, concerns arose that DS would possibly
amage the polymer coating and change or diminish the
fficacy of the programmed drug release. A post-hoc analysis
f the TAXUS II trial has shown that DS with the
olymer-based paclitaxel-eluting TAXUS stent (Boston
cientific Corporation, Natick, Massachusetts) is feasible,
afe, and equally effective (26). Recently, other studies have
andomly compared DS and CS with drug-eluting stents. In
hese studies (13,27), DS has been associated with less
eointimal hyperplasia near the distal stent edge (13) and
esulted in a significantly lower rate of target lesion revas-
ularization over a 12-month follow-up period compared
Figure 3 Relationship Between Individual IMR Values
and Corresponding CFR and FFR Post-PCI
(A) Correlation between post-PCI IMR and CFR values, r  0.38, p  0.006.
(B) Correlation between post-PCI IMR and FFR values, r  0.15, p  0.1. Abbre-
viations as in Figures 1 and 2.
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March 18, 2008:1060–5 Direct Stenting and Microcirculatory Injuryith balloon pre-dilation followed by stenting (27). In the
resent study, using IMR as a novel and sensitive invasive
arker of microcirculatory injury, we have shown that DS
as associated with lower values of IMR, which tended to
esult in lower rates of post-PCI troponin release compared
ith CS.
tudy limitations. The length of time these microvascular
isturbances persist and their prognostic significance, if any
n absence of troponin increase, are not known. The sample
ize is relatively small, and randomization groups may not
e entirely balanced.
onclusions
he results of the present study suggested a lower rate of
icrovascular injury, evaluated with IMR, after otherwise
ncomplicated DS versus CS. These data suggest that DS
ay be the preferred implantation technique in suitable
atients undergoing elective PCI for stable angina pectoris.
eprint requests and correspondence: Dr. William Wijns, Car-
iovascular Center Aalst, Moorselbaan 164, B 9300 Aalst, Bel-
ium. E-mail: William.Wijns@village.uunet.be.
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